112 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
of the last signature affixed hereto, by and between Processa Pharmaceuticals Inc., a Delaware corporation (“Processa”), and R. Michael Floyd, (“Employee … acknowledged, Processa and Employee hereby agree as follows:
Position of Employment. Processa will employ the Employee in the position of Chief
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
3 Nov 14
Separation and Severance Agreement
12:00am
agreement agreed to between Alexander Kramer (hereinafter ''Employee") and Heatwurx, Inc. (hereinafter "Employer"), in connection with the termination … and severance of the Employee's employment from Employer and to waive and release any claims by the Employee against the Employer.
In consideration
8-K
EX-3.1
wnc 6vymda
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
DEF 14A
f2seu762z9 7afn7dt
26 Apr 19
Definitive proxy
5:02pm
10-K
EX-3.2
x8y 28kt8wmc448l
27 Mar 14
Annual report
12:00am
8-K
EX-1.1
puydpe3skje047v
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
S-3
s205a6 tg9
2 Apr 21
Shelf registration
12:00am